← Stack Research Tool

Pair page

AHK-Cu with GHK-Cu

Mechanism-tag overlap and published literature for AHK-Cu and GHK-Cu, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.

Mechanism overlap

Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.

AHK-CU GHK-CU 3 UNIQUE TAGS 2 UNIQUE TAGS 0 SHARED
AHK-Cu unique copper-tripeptidecosmetic-peptidehair
Shared none
GHK-Cu unique connective-tissuecopper-tripeptide-skin

Co-administration notes from the literature

Verbatim summary text pulled from each compound's profile data. Researchers studying AHK-Cu and GHK-Cu have published these mechanism-level observations. Not a co-administration recommendation.

Evidence level: mechanistic only

The most common AHK-Cu pairing. GHK-Cu brings broader wound-healing, collagen-synthesis, anti-inflammatory, and gene-expression-modulation biology; AHK-Cu brings a reported selectivity toward dermal papilla cells and hair-follicle elongation. Commercial serums commonly combine ~0.1% of each (total 0.2% copper tripeptides). Mechanistically plausible; direct head-to-head or combination-product RCT data is limited.

Quick facts

AHK-Cu

RouteTopical scalp
Half-lifeNot listed
FDA statusCosmetic ingredient
WADANot listed (N/A topical)
Full AHK-Cu profile →

GHK-Cu

RouteTopical > SubQ
Half-lifeMinutes (plasma); longer topical residence
FDA statusCosmetic ingredient; Category 2 for injection
WADANot specifically named; plausibly S0 by analogy
Full GHK-Cu profile →

Literature table

Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.

Year Compound Source Finding
2013AHK-CuDhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study. Int J Trichology. 2013;5(1):6-11. doi:10.4103/0974-7753.114700. PMID: 23960389. (Microneedling + minoxidil RCT — the pr… PMID 23960389human trial
1998AHK-CuLachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138(3):407-411. doi:10.1046/j.1365-2133.1998.02115.x. PMID: 9580790. (Clinically validated positive-contr… PMID 9580790human study
2001AHK-CuYano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest. 2001;107(4):409-417. doi:10.1172/JCI11317. PMID: 11181640. (Transgenic VEGF overexpression increases perifollicular vascularization, accelerates hair regrowth, and… PMID 11181640preclinical, in vivo
2007AHK-CuPyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833. PMID: 17703734. (The foundational AHK-Cu in-vitro / ex-vivo paper — dermal papilla… PMID 17703734preclinical, in vitro
1988AHK-CuMaquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. doi:10.1016/0014-5793(88)80509-x. PMID: 3169264. (Found… PMID 3169264preclinical, in vitro
2018AHK-CuPickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987. PMID: 29986520. (Comprehensive review of copper-peptide gene-expression effects — scaffold for AHK-Cu me… PMID 29986520review
2008AHK-CuPickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435. PMID: 18644225. (Authoritative Pickart review of the copper-peptide tissue-remodeling framework.) PMID 18644225review
2015AHK-CuPickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108. PMID: 26236730. (Multi-pathway copper-peptide mechanism review — foundational context for… PMID 26236730research article
2012AHK-CuLi W, Man XY, Li CM, Chen JQ, Zhou J, Cai SQ, Lu ZF, Zheng M. VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK. Exp Cell Res. 2012;318(14):1633-1640. doi:10.1016/j.yexcr.2012.05.003. PMID: 22659165. (Downstream VEG… PMID 22659165research article
2012AHK-CuPickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi:10.1155/2012/324832. PMID: 22666519. (Copper-peptide agi… PMID 22666519research article
2000AHK-CuSiméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-968. doi:10.1046/j.1523-1747.2000.00166.x. PMID: 1… PMID 11121126research article
1999AHK-CuSimeon A, Monier F, Emonard H, Gillery P, Birembaut P, Hornebeck W, Maquart FX. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 1999;112(6):957-964. doi:10.1046/j.… PMID 10383745research article
1995GHK-CuBuffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of healing of cutaneous wounds in mice. Arch Int Pharmacodyn Ther. 1995;330(3):345-360. PMID: 9060874. PMID 9060874preclinical, in vivo
1993GHK-CuMaquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376. PMID: 8227353. PMID 8227353preclinical, in vivo
2011GHK-CuHostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86. PMID: 20835751. PMID 20835751preclinical, in vitro
2007GHK-CuPyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. PMID: 17702486. PMID 17702486preclinical, in vitro
2017GHK-CuPickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017;7(2):20. PMID: 28212278. PMID 28212278mechanism / discovery
2012GHK-CuCampbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PMID: 22937864. PMID 22937864mechanism / discovery
1973GHK-CuPickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID: 4351857. (Original discovery publication.) PMID 4351857mechanism / discovery
2026GHK-CuWADA Prohibited List 2026. World Anti-Doping Agency. wada-ama.org.regulatory / registry
2025GHK-CuFDA. Bulk Drug Substances That Raise Significant Safety Risks (Category 2) Under Section 503A / 503B. FDA.gov. Updated 2025-2026.regulatory / registry
2012GHK-CuPickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666521. PMID 22666521research article
2012GHK-CuGruchlik A, Jurzak M, Chodurek E, Dzierzewicz Z. Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2012;69(6):1303-1306. PMID: 23285693. PMID 23285693research article
2012GHK-CuTrapaidze A, Hureau C, Bal W, Winterhalter M, Faller P. Thermodynamic study of Cu²⁺ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. J Biol Inorg Chem. 2012;17(1):37-47. PMID: 21748269. PMID 21748269research article

Related pair pages

More research context

Frequently asked

Have AHK-Cu and GHK-Cu been studied together?

Researchers have published mechanistic-level co-administration discussion of AHK-Cu and GHK-Cu. No human co-administration trials are catalogued in the Kalios profiles. The pair page lists each compound's classified literature; full citations sit on each individual profile.

What mechanisms do AHK-Cu and GHK-Cu share?

AHK-Cu and GHK-Cu do not share a specific mechanism tag on their Kalios profiles. They appear on the same pair page because at least one profile lists the other in its co-administration data.

What is the FDA status of AHK-Cu and GHK-Cu?

AHK-Cu: Cosmetic ingredient. GHK-Cu: Cosmetic ingredient; Category 2 for injection. FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.

Where can I find the full research on AHK-Cu and GHK-Cu?

Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the AHK-Cu profile and the GHK-Cu profile. The Kalios Stack Research Tool hub lists every compound covered.

Last updated: April 2026